Evidence map›Paper›PMID 33448171›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2020

[Chinese medicine Buyang Huanwu decoction promotes neurogenesis and angiogenesis in ischemic stroke rats by upregulating miR-199a-5p expression].

Lujie Zhuge, Yan Fang, Huaqian Jin, Lin Li, Yan Yang, Xiaowei Hu, Lisheng Chu

Open access · greenAbstract read
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lujie ZhugeCollege of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yan FangCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Huaqian JinCollege of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Lin LiCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yan YangCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xiaowei HuCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Lisheng ChuCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhejiang Chinese Medical University · CNChina Academy of Chinese Medical Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the mechanism of Chinese medicine Buyang Huanwu decoction (BYHWD) promoting neurogenesis and angiogenesis in ischemic stroke rats.

methodsMale SD rats were randomly divided into sham operation group, model group, BYHWD group, antagonist group and antagonist control group with 14 rats in each. Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery for 90 min with intraluminal filament and reperfusion for 14 d in all groups except sham operation group. BYHWD (13 g/kg) was administrated by gastrogavage in BYHWD group, antagonist group and antagonist control group at 24 h after modeling respectively, and BrdU (50 mg/kg) was injected intraperitoneally in all groups once a day for 14 consecutive days. miR-199a-5p antagomir or NC (10 nmol) was injected into the lateral ventricle at d5 after ischemia in antagonist and antagonist control groups, respectively. The neurological deficits were evaluated by the modified neurological severity score (mNSS) and the corner test, and the infract volume was measured by toluidine blue staining. Neurogenesis and angiogenesis were detected by immunofluorescence double labeling method. The expression level of miR-199a-5p was tested by real-time RT-PCR, and the protein expressions of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) were determined by Western blotting.

resultsBYHWD treatment significantly promoted the recovery of neurological function (

conclusionsBuyang Huanwu decoction promotes neurogenesis and angiogenesis in rats with cerebral ischemia, which may be related to increased protein expression of VEGF and BDNF through upregulating miR-199a-5p.

Indexed as

Drugs, Chinese HerbalIschemic StrokeMicroRNAsNeurogenesisUp-RegulationAnimalsBrain IschemiaDoublecortin ProteinMaleRatsRats, Sprague-DawleyVascular Endothelial Growth Factor Abuyang huanwuDcx protein, ratDoublecortin ProteinDrugs, Chinese HerbalMicroRNAsMIRN199 microRNA, ratVascular Endothelial Growth Factor AAngiogenesisBuyang Huanwu decoctionCerebral ischemiamicroRNAmiR-199a-5pNeurogenesisRats, Sprague-Dawley

Identifiers

PMID33448171
PMCPMC10412415
OpenAlexW3118817936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.